[
1. Armstrong DG, Boulton AJM, Bus SA. Diabetic Foot Ulcers and Their Recurrence. N. Engl. J. Med. 2017; 376: 2367-75.
]Search in Google Scholar
[
2. Ertuğrul MB, Baktıroğlu S. Diabetic foot and osteomyelitis. J Klimik. 2005; 1: 8-13.
]Search in Google Scholar
[
3. Lavery LA, Armstrong DG, Murdoch DP, Peters EJ, Lipsky BA. Validation of the Infectious Diseases Society of America’s diabetic foot infection classification system. Clin Infect Dis. 2007; 44: 562-5.10.1086/51103617243061
]Search in Google Scholar
[
4. Ndosi M, Wright-Hughes A, Brown S, et al. Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study. Diabet Med. 2018; 35: 78-88.10.1111/dme.13537576551229083500
]Search in Google Scholar
[
5. IWGDF Guideline on the diagnosis and treatment of foot infection in persons with diabetes [https://iwgdfguidelines.org/wp-content/uploads/2019/05/05-IWGDF-infection-guideline-2019.pdf] (Elérve: 2020.09.23)
]Search in Google Scholar
[
6. Alonso-Coello P, Oxman AD, Moberg J, et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines. BMJ. 2016; 353: 2089.10.1136/bmj.i208927365494
]Search in Google Scholar
[
7. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336: 924-6.10.1136/bmj.39489.470347.AD233526118436948
]Search in Google Scholar
[
8. Senneville E, Abbas ZG, Aragón-Sánchez J, et al. Diagnosis of infection in the foot in diabetes: a systematic review. Diabetes Metabol Res Rev. 2019; 36: 3281.
]Search in Google Scholar
[
9. Peters EJG, Senneville E, Abbas ZG, et al. Interventions in the management of infection in the foot in diabetes: a systematic review (update). Diabetes Metabol Res Rev. 2020; 36: 3282.10.1002/dmrr.328232176437
]Search in Google Scholar
[
10. Uçkay I, Gariani K, Pataky Z, Lipsky BA. Diabetic foot infections: state-of-the-art. Diabetes Obes Metab. 2014; 16: 305-16.10.1111/dom.1219023911085
]Search in Google Scholar
[
11. Rosskopf AB, Loupatatzis C, Pfirrmann CWA, Böni T, Berli MC. The Charcot foot: a pictorial review. Insights Imaging. 2019; 10: 77.10.1186/s13244-019-0768-9668284531385060
]Search in Google Scholar
[
12. Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012; 54: 132-73.10.1093/cid/cis34622619242
]Search in Google Scholar
[
13. Rajbhandari SM, Sutton M, Davies C, et al. ‚Sausage toe’: a reliable sign of underlying osteomyelitis. Diabet Med. 2000; 17: 74-7.10.1046/j.1464-5491.2000.00194.x10691164
]Search in Google Scholar
[
14. Ertuğrul BM, Savk O, Öztürk B, Çobanoğlu M, Öncü S, Sakarya S. The diagnosis of diabetic foot osteomyelitis: examination findings and laboratory values. Med Sci Monit. 2009; 15: 307-12.
]Search in Google Scholar
[
15. Newman LG, Waller J, Palestro CJ, et al. Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline. JAMA. 1991; 266: 1246-51.10.1001/jama.1991.03470090080036
]Search in Google Scholar
[
16. Tülek N, et al. A prospective, multi-center study: factors related to the management of diabetic foot infections. Eur J Clin Microbiol Infect Dis. 2012; 31: 2345-2352.10.1007/s10096-012-1574-1
]Search in Google Scholar
[
17. Berendt AR, Peters EJ, Bakker K, et al. Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. Diabetes Metab Res Rev. 2008; 24: 145-61.10.1002/dmrr.836
]Search in Google Scholar
[
18. Butalia S, Palda VA, Sargeant RJ, Detsky AS, Mourad O. Does this patient with diabetes have osteomyelitis of the lower extremity? JAMA. 2008; 299: 806-13.
]Search in Google Scholar
[
19. Cavanagh PR, Lipsky BA, Bradbury AW, Botek G. Treatment for diabetic foot ulcers. Lancet. 2005;366: 1725-35.10.1016/S0140-6736(05)67699-4
]Search in Google Scholar
[
20. Gajdács M, Spengler G, Urbán E. Identification and Antimicrobial Susceptibility Testing of Anaerobic Bacteria: Rubik’s Cube of Clinical Microbiology? Antibiotics 2017; 6: 25.
]Search in Google Scholar
[
21. Lipsky BA, Peters EJ, Senneville E, et al. Expert opinion on the management of infections in the diabetic foot. Diabetes Metab Res Rev. 2012; 28: 163-78.10.1002/dmrr.224822271739
]Search in Google Scholar
[
22. Ertuğrul MB, Baktıroğlu S, Aksoy M, Çalangu S. Diabetic foot and infection. J Klimik. 2004;17: 3-12.
]Search in Google Scholar
[
23. Lipsky BA. Osteomyelitis of the foot in diabetic patients. Clin Infect Dis. 1997; 25: 1318-1326.10.1086/5161489431370
]Search in Google Scholar
[
24. Lipsky BA. Bone of contention: diagnosing diabetic foot osteomyelitis. Clin Infect Dis. 2008; 47: 528-30.10.1086/59001218611161
]Search in Google Scholar
[
25. Lipsky BA. Diagnosing and Treating Diabetic Foot Infections. Klimik Derg. 2009; 22: 2-13.
]Search in Google Scholar
[
26. Lam K, van Asten SA, Nguyen T, La Fontaine J, Lavery LA. Diagnostic Accuracy of Probe to Bone to Detect Osteomyelitis in the Diabetic Foot: A Systematic Review. Clin Infect Dis. 2016;63: 944-8.10.1093/cid/ciw44527369321
]Search in Google Scholar
[
27. Uzun G, Solmazgül E, Çürüksulu H, et al. Procalcitonin as a diagnostic aid in diabetic foot infections. Tohoku J Exp Med. 2007; 213: 305-12.10.1620/tjem.213.30518075234
]Search in Google Scholar
[
28. Ertuğrul MB. Diabetic foot infections. Türkiye Klinikleri J Gen Surg-Special Topics. 2010; 3: 46-56.
]Search in Google Scholar
[
29. Van Asten SA, Jupiter DC, Mithani M, La Fontaine J, Davis KE, Lavery LA. Erythrocyte sedimentation rate and C- reactive protein to monitor treatment outcomes in diabetic foot osteomyelitis. Int Wound J. 2017;14: 142-8.10.1111/iwj.12574795014426953894
]Search in Google Scholar
[
30. Jeffcoate WJ, Lipsy BA. Controversies in diagnosing and managing osteomyelitis of the foot in diabetes. Clin Infect Dis. 2004; 39: 115-22.10.1086/38327215306989
]Search in Google Scholar
[
31. Beaman FD, Wessell DE, Cassidy RC, et al. ACR Appropriateness Criteria® Suspected Osteomyelitis of the Foot in Patients with Diabetes Mellitus. Expert Panel on Musculoskeletal Imaging. J Am Coll Radiol. 2019; 16: 440-50.
]Search in Google Scholar
[
32. Llewellyn A, Jones-Diette J, Kraft J, Holton C, Harden M, Simmonds M. Imaging tests for the detection of osteomyelitis: a systematic review. Health Technol Assess. 2019;23: 1-128.10.3310/hta23610684311431670644
]Search in Google Scholar
[
33. Ertuğrul MB, Baktiroğlu S, Salman S, et al. The diagnosis of osteomyelitis of the foot in diabetes: microbiological examination vs. magnetic resonance imaging and labelled leucocyte scanning. Diabet Med. 2006; 23: 649-53.10.1111/j.1464-5491.2006.01887.x16759307
]Search in Google Scholar
[
34. Gariani K, Uçkay I, Lipsky BA. Managing diabetic foot infections: a review of the new guidelines. Acta Chir Belg. 2014; 114 :7-16.10.1080/00015458.2014.11680970
]Search in Google Scholar
[
35. Glaudemans AW, Uçkay I, Lipsky BA. Challenges in diagnosing infection in the diabetic foot. Diabet Med. 2015; 32: 748-59.10.1111/dme.1275025765225
]Search in Google Scholar
[
36. Al-Mayahi M, Cian A, Lipsky BA, et al. Administration of antibiotic agents before intraoperative sampling in orthopedic infections alters culture results. J Infect. 2015; 71: 518-25.10.1016/j.jinf.2015.08.00226283328
]Search in Google Scholar
[
37. Jude EB, Selby PL, Mawer EB, et al. Inflammatory and bone turnover markers in Charcot arthropaty and osteomyelitis of the feet in diabetic patients (abstract). Diabetologia. 2002; 45: 341-2.
]Search in Google Scholar
[
38. Çildağ MB, Ertuğrul BM, Köseoğlu OF, Çildağ S, Armstrong DG. Angiographic assessment of atherosclerotic load at the lower extremity in patients with diabetic foot and Charcot neuroarthropathy. J Chin Med Assoc. 2018; 81: 565-70.10.1016/j.jcma.2017.09.00629056486
]Search in Google Scholar
[
39. Senneville E, Morant H, Descamps D, et al. Needle puncture and transcutaneous bone biopsy cultures are inconsistent in patients with diabetes and suspected osteomyelitis of the foot. Clin Infect Dis. 2009; 48: 888-93.10.1086/59726319228109
]Search in Google Scholar
[
40. Nelson A, Wright-Hughes A, Backhouse MR, et al. CODIFI (Concordance in Diabetic Foot Ulcer Infection): a cross-sectional study of wound swab versus tissue sampling in infected diabetic foot ulcers in England. BMJ Open. 2018; 8: 019437.10.1136/bmjopen-2017-019437587972929391370
]Search in Google Scholar
[
41. Gajdács M, Urbán E. The relevance of anaerobic bacteria in brain abscesses: a ten-year retrospective analysis (2008-2017). Infect Dis (Lond). 2019; 51: 779-781.10.1080/23744235.2019.164885731368384
]Search in Google Scholar
[
42. Gajdács M, Urbán E. Relevance of anaerobic bacteremia in adult patients: A never-ending story? Eur. J. Microbiol. Immunol 2020; 10: 64-75.
]Search in Google Scholar
[
43. Hatipoğlu M, Mutluoğlu M, Uzun G, Karabacak E, Turhan V, Lipsky BA. The microbiologic profile of diabetic foot infections in Turkey: a 20-year systematic review: diabetic foot infections in Turkey. Eur J Clin Microbiol Infect Dis. 2014; 33: 871-8.10.1007/s10096-014-2047-524452966
]Search in Google Scholar
[
44. Tumminello A, Dominguez D, Lebowitz D, et al. Staphylococcus aureus versus streptococci in orthopaedic infections. Infect Dis (Lond). 2017; 49: 716-8.10.1080/23744235.2017.131821928467136
]Search in Google Scholar
[
45. Uçkay I, Pires D, Agostinho A, et al. Enterococci in orthopaedic infections: Who is at risk getting infected? J Infect. 2017; 75: 309-14.
]Search in Google Scholar
[
46. Gariani K, Lebowitz D, von Dach E, Kressmann B, Lipsky BA, Uçkay I. Remission in diabetic foot infections: Duration of antibiotic therapy and other possible associated factors. Diabetes Obes Metab. 2019; 21: 244-51.10.1111/dom.1350730129109
]Search in Google Scholar
[
47. Gajdács M. Epidemiology and resistance trends of Staphylococcus aureus isolated from vaginal samples: a 10-year retrospective study in Hungary. Acta Dermatovenerol Alp Pannonica Adriat. 2019; 28: 143-147.10.15570/actaapa.2019.35
]Search in Google Scholar
[
48. Percival SL, Malone M, Mayer D, Salisbury AM, Schultz G. Role of anaerobes in polymicrobial communities and biofilms complicating diabetic foot ulcers. Int Wound J. 2018; 15: 776-82.10.1111/iwj.12926795014629863794
]Search in Google Scholar
[
49. Charles PG, Uçkay I, Kressmann B, Emonet S, Lipsky BA. The role of anaerobes in diabetic foot infections. Anaerobe. 2015; 34: 8-13.10.1016/j.anaerobe.2015.03.00925841893
]Search in Google Scholar
[
50. Uçkay I, Gariani K, Dubois-Ferrière V, Suvà D, Lipsky BA. Diabetic foot infections: recent literature and cornerstones of management. Curr Opin Infect Dis. 2016; 29: 145-52.10.1097/QCO.000000000000024326779774
]Search in Google Scholar
[
51. Selva Olid A, Solà I, Barajas-Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database Syst Rev. 2015; 9: CD009061.10.1002/14651858.CD009061.pub2850498826337865
]Search in Google Scholar
[
52. Gajdács M, Burián K, Terhes G. Resistance Levels and Epidemiology of Non-Fermenting Gram-Negative Bacteria in Urinary Tract Infections of Inpatients and Outpatients (RENFUTI): A 10-Year Epidemiological Snapshot. Antibiotics 2019; 9: 143.10.3390/antibiotics8030143678425631505817
]Search in Google Scholar
[
53. Lebowitz D, Gariani K, Kressmann B, et al. Are antibiotic-resistant pathogens more common in subsequent episodes of diabetic foot infection? Int J Infect Dis. 2017; 59: 61-4.
]Search in Google Scholar
[
54. Uckay I, Berli M, Sendi P, Lipsky BA. Principles and practice of antibiotic stewardship in the management of diabetic foot infections. Curr Opin Infect Dis. 2019; 32: 95-101.10.1097/QCO.000000000000053030664029
]Search in Google Scholar
[
55. CDC. Core Elements of Hospital Antibiotic Stewardship Programs. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. [https://www.cdc.gov/antibioticuse/healthcare/pdfs/hospital-core-elements-H.pdf] (Elérve: 2020.09.23)
]Search in Google Scholar
[
56. Post V, Wahl P, Uçkay I, et al. Phenotypic and genotypic characterisation of Staphylococcus aureus causing musculoskeletal infections. Int J Med Microbiol. 2014; 304: 565-76.10.1016/j.ijmm.2014.03.00324768432
]Search in Google Scholar
[
57. Zenelaj B, Bouvet C, Lipsky BA, Uçkay I. Do diabetic foot infections with methicillin-resistant Staphylococcus aureus differ from those with other pathogens? Int J Low Extrem Wounds. 2014; 13: 263-72.
]Search in Google Scholar
[
58. Goldstein EJ, Citron DM, Warren YA, Tyrrell KL, Merriam CV, Fernandez HT. In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections. Antimicrob Agents Chemother. 2006; 50: 2875-9.10.1128/AAC.00286-06153869316870792
]Search in Google Scholar
[
59. Gajdács M, Albericio F. Antibiotic Resistance: From the Bench to Patients. Antibiotics 2019; 8: 129.10.3390/antibiotics8030129678386831461842
]Search in Google Scholar
[
60. Malik A, Mohammad Z, Ahmad J. The diabetic foot infections: biofilms and antimicrobial resistance. Diabetes Metab Syndr. 2013; 7: 101-7.10.1016/j.dsx.2013.02.00623680250
]Search in Google Scholar
[
61. Vatan A, Saltoğlu N, Yemisen L, et al. Association between biofilm and multi/extensive drug resistance in diabetic foot infection. Int J Clin Pract. 2018; 72: e13060.10.1111/ijcp.1306029381248
]Search in Google Scholar
[
62. Johani K, Fritz BG, Bjarnsholt T, et al. Understanding the microbiome of diabetic foot osteomyelitis: insights from molecular and microscopic approaches. Clin Microbiol Infect. 2019; 25: 332-9.10.1016/j.cmi.2018.04.03629787888
]Search in Google Scholar
[
63. Wilson BM, Bessesen MT, Doros G, et al. Adjunctive Rifampin Therapy For Diabetic Foot Osteomyelitis in the Veterans Health Administration. JAMA Netw Open. 2019; 2: 1916003.10.1001/jamanetworkopen.2019.16003690281431755948
]Search in Google Scholar
[
64. Senneville E, Yazdanpanah Y, Cazaubiel M, et al. Rifampicinofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis. J Antimicrob Chemother. 2001; 48: 927-30.10.1093/jac/48.6.92711733482
]Search in Google Scholar
[
65. Wilson BM, Bessesen MT, Doros G, Brown ST, Saade E, Hermos J, Perez F, Skalweit M, Spellberg B, Bonomo RA. Adjunctive Rifampin Therapy For Diabetic Foot Osteomyelitis in the Veterans Health Administration. JAMA Netw Open 2019; 2: e1916003.10.1001/jamanetworkopen.2019.16003
]Search in Google Scholar
[
66. Lipsky BA. Treating diabetic foot osteomyelitis primarily with surgery or antibiotics: have we answered the question? Diabetes Care. 2014; 37: 593-5.
]Search in Google Scholar
[
67. Kosinski MA, Lipsky BA. Current medical management of diabetic foot infections. Expert Rev Anti-Infect Ther 2010; 8: 1293-1305.10.1586/eri.10.12221073293
]Search in Google Scholar
[
68. Lazaro-Martinez JL, Aragon-Sanchez J, Garcia-Morales E. Antibiotics versus conservative surgery for treating diabetic foot osteomyelitis: a randomized comparative trial. Diabetes Care. 2014; 37: 789-95.10.2337/dc13-152624130347
]Search in Google Scholar
[
69. Matthews PC, Berendt AR, Lipsky BA. Clinical management of diabetic foot infection: diagnostics, therapeutics and the future. Expert Rev Anti-Infect Ther 2007; 5: 117-127.10.1586/14787210.5.1.11717266459
]Search in Google Scholar
[
70. Tone A, Nguyen S, Devemy F, et al. Six-week versus twelve-week antibiotic therapy for nonsurgically treated diabetic foot osteomyelitis: A multicenter open label controlled randomized study. Diabetes Care. 2015; 38: 302-7.10.2337/dc14-151425414157
]Search in Google Scholar
[
71. Waibel F, Berli M, Catanzaro S, et al. Optimization of the antibiotic management of diabetic foot infections: protocol for two randomized-controlled trials. Trials. 2020; 21: 54.10.1186/s13063-019-4006-z695086731915048
]Search in Google Scholar
[
72. Shiraev TP, Lipsky BA, Kwok TMY, Robinson DA. Utility of Culturing Marginal Bone in Patients Undergoing Lower Limb Amputation for Infection. J Foot Ankle Surg. 2019; 58: 847-51.10.1053/j.jfas.2018.12.01231345756
]Search in Google Scholar
[
73. Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database Syst Rev. 2017; 6: CD011038.10.1002/14651858.CD011038.pub2648188628613416
]Search in Google Scholar
[
74. Uçkay I, Kressmann B, Di Tommaso S, et al. A randomized controlled trial of the safety and efficacy of a topical gentamicin-collagen sponge in diabetic patients with a mild foot ulcer infection. SAGE Open Med. 2018; 6: 2050312118773950.10.1177/2050312118773950595457429785265
]Search in Google Scholar
[
75. Uçkay I, Kressmann B, Malacarne S, et al. A randomized, controlled study to investigate the efficacy and safety of a topical gentamicin-collagen sponge in combination with systemic antibiotic therapy in diabetic patients with a moderate or severe foot ulcer infection. BMC Infect Dis. 2018; 18: 361.10.1186/s12879-018-3253-z609084730068306
]Search in Google Scholar
